16th January 2024
European Rare Diseases Research Alliance (ERDERA)
ERDERA proposal was submitted under Horizon Europe on 19 Sept. 2023 for funding under the EU Research & Innovation funding programme Horizon Europe as a co-funded partnership between the European Commission, European Member States, and beyond.
- Presented by Yanis Mimouni and Daria Julkowska, European Joint Programme on Rare Diseases
- Webinar PDF presentation: Have a look at the PDF presentation, click here
- Webinar REPLAY: This content is reserved for ERN-Skin members and healthcare professionals.
30th January 2024
EBStatMax
EBStatMax is a clinical trials methodology demonstration project co-funded by the European Joint Programme on Rare Diseases (EJP-RD)
- Presented by Johann Bauer, University Hospital Salzburg, Austria
27th February 2024, 1:00 pm – 2:00 pm CET
Long-Term Sustained Complete Remission Off Corticosteroid Therapy in Patients with Pemphigus Who Received Rituximab as First-Line Therapy: Results From a Median 7-Year Follow-up Study of the Ritux 3 Trial
- Presented by Prof. Pascal Joly, from Centre de Référence Maladies Bulleuses Auto-immunes, Clinique dermatologique CHU de Rouen, Rouen France.
- Chaired by Prof. Branka Marinović, from Zagreb Clinical Hospital Center, Zagreb, Croatia.
Organized by thematic group on AutoImmune Bullous Diseases (AIBD)
27th March 2024, 1:00 pm – 2:00 pm CET
Please note: Exceptionally this webinar takes place on Wednesday instead of Tuesday
Recent findings on: “GNAQ/GNA11 Mosaicism Causes Aberrant Calcium Signaling Susceptible to Targeted Therapeutics.”
- Presented by Prof. Veronica Kinsler. Professor of Paediatric Dermatology and Dermatogenetics – Great Ormond St Hospital for Children, London, UK.
- Chaired by Dr. Andrea Diociaiuti. Dipartimento Pediatrico Universitario Ospedaliero. IRCCS Ospedale Pediatrico Bambino Gesù – SEDE GIANICOLO, Italy.
Organized by thematic group on Cutaneous Mosaic Disorders Naevi & Naevoid skin disorders, complex vascular malformations and vascular tumors (MOSAIC)
30th April 2024, 1:00 pm – 2:00 pm CET
Recent paper about the involvement of TFIIH in DNA repair diseases and therapeutic perspectives.
- Presented by Dr. Arjan Theil from Erasmus University Medical Centre Rotterdam, Rotterdam, Netherlands.
- Chaired by Dr. Fanny Morice-Picard from CHU de Bordeaux, Centre de Référence pour les Maladies Rares de la Peau (CRMRP), Bordeaux, France.
Organized by thematic group on Cutaneous Diseases related to DNA repair Disorders and photosensitivity (DNA+)
28th May 2024, 1:00 pm – 2:00 pm CET
Thymic dysplasia, autoantibodies to type I IFNs, and viral diseases in women with incontinentia pigmenti.
- Presented by Dr. Jérémie Rosain, DMU BioPhyGen, AP-HP. Centre-Université Paris Cité laboratoire de Génétique Humaine des Maladies Infectieuses, Institut, Imagine and Centre d’Étude des Déficits Immunitaires (CEDI), Hôpital Necker-Enfants malades, Paris, France.
- Chaired by Prof. Smail Hadj-rabia, Hôpital Necker-Enfants malades, Paris, France.
Organized by thematic group on Ectodermal Dysplasias including Incontinentia Pigmenti and p63-associated disorders (ED)
26th November 2024, 1:00 pm – 2:00 pm CET
Skin in Manifestations in EDS: what are they and how to manage them
-
Presented by:
- Prof. Dr. Fransiska Malfait, from Centre for Medical Genetics Ghent, Ghent, Belgium.
- Prof. Clair A. Francomano, Professor of Medical and Molecular Genetics at Indiana University, Indiana, USA.
- Chaired by Prof. Dr. Bert Callewaert, from Centre for Medical Genetics Ghent, Ghent, Belgium.
Organized by the thematic group on Mendelian connective tissue disorders (MCTD)
17th December 2024, 1:30 pm – 2:30 pm CET
Severe cutaneous adverse reactions and their mimickers associated with cancer treatments
- Speaker: Prof. Dr. Chia-Yu Chu, from Department of Dermatology National Taiwan University Hospital, Taiwan.
- Chaired by Prof. Dr. Saskia Oro, from Hôpital Henri-Mondor AP-HP, Paris, France.
Organized by the thematic group on Severe Cutaneous Drug Reactions – Toxic Bullous Diseases (ToxiTEN)